Swiss pharma giant Roche agrees $7.1 billion deal to buy Telavant Holdings

Swiss health care company Roche announced it would acquire Telavant Holdings Monday, in a deal worth $7.1 billion.

Telavant creates drugs for people suffering from inflammatory and fibrotic diseases, and is in the process of developing a"promising new therapy" for patients with Crohn's disease, Roche said in a press release.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

NBCDFW /  🏆 288. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

Roche to Buy Telavant From Roivant Sciences and Pfizer in $7.25 Bln DealBy Adria Calatayud Roche Holding has agreed to buy Telavant Holdings from Roivant Sciences and Pfizer in a deal worth up to $7.25 billion that will give it...
Les mer »

This Swiss Company Wants to Use Excess Energy From Food Production to Mine BitcoinCrypto Blog
Les mer »

Anti-EU, anti-immigration party set to sweep Swiss pollsThe right-wing populist SVP's election campaign has focused on its favourite theme: the fight against 'mass immigration' and saying no to a Switzerland of 10 million people.
Les mer »

Populist Right Set to Sweep Swiss PollsRight-wing populists looked set to sweep Switzerland's general election as the votes were being counted Sunday following a campaign fuelled by anti-mass migration rhetoric and pledges to combat 'woke madness'.The polling stations closed at noon (1000 GMT), the vast majority...
Les mer »

Exit poll shows Swiss right-wing party bouncing back in parliamentary election as Greens lose groundExit polls showed Switzerland's right-wing populist party was set to further strengthen its position as the largest faction in parliament.
Les mer »

Swiss turn to right at election as immigration fears weighSwiss turn to right at election as immigration fears weigh
Les mer »